Recently, agonists of glucagon-like peptide-1 (GLP-1) receptor, designed based on the gut hormone GLP-1, have been developed as anti-obesity drugs and have demonstrated remarkable efficacy in treating both obesity and diabetes
Focus on Protein Density, Not Portion Size When appetite is lower, protein per bite matters more than volume
A slower transition gives your body more time to adjust as the medications appetite-suppressing effects wear off
Still preclinical, but the therapeutic logic is elegant
Lower enzyme levels often indicate reduced liver inflammation and better liver function, although results can vary based on individual health status and consistency of use
However, consult your gastroenterologist if youre taking a GLP-1 medication and experiencing persistent digestive issues